Edition:
India

Agile Therapeutics Inc (AGRX.OQ)

AGRX.OQ on NASDAQ Stock Exchange Capital Market

1.19USD
1:30am IST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.19
Open
$1.20
Day's High
$1.22
Day's Low
$1.18
Volume
266,768
Avg. Vol
104,843
52-wk High
$1.70
52-wk Low
$0.53

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.125
FY 2018 Dec '18 0.00 -0.111
Sep '18 0.00 -0.110
Jun '18 0.00 -0.156
Mar '18 0.00 -0.200
FY 2017 Dec '17 0.00 -0.182
Sep '17 0.00 -0.222
Jun '17 0.00 -0.259
Mar '17 0.00 -0.261
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-19 6 0.00 0.00 0.00 --
Quarter Ending Mar-20 2 0.00 0.00 0.00 --
Year Ending Dec-19 6 0.00 0.00 0.00 10.62
Year Ending Dec-20 6 21.48 38.40 5.03 62.11
Earnings (per share)
Quarter Ending Dec-19 6 -0.10 -0.06 -0.14 --
Quarter Ending Mar-20 2 -0.14 -0.12 -0.16 --
Year Ending Dec-19 6 -0.44 -0.34 -0.52 -0.79
Year Ending Dec-20 6 -0.33 0.11 -0.85 -0.47
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 36.99 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Agile Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -10.96 -13.43 29 --
13 Week -13.33 -15.80 49 --
26 Week 53.12 34.85 87 --
52 Week 334.02 307.00 99 --
YTD 125.73 87.01 92 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 55.29%
# of Holders: 38
Total Shares Held: 24,186,340
3 Mo. Net Change: 1,039
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 1
# Reduced Positions: 1
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.